Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip S Jones

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|December 13, 2003
Adherence to advance directives: maybe doctors do not always know bestPhilip S Jones
Drug Discovery Today|October 11, 2016
The SULSA Assay Development Fund: accelerating translation of new biology from academia to pharmaStuart P McElroy, Philip S Jones, Denise V Barrault
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 4, 2003
Chemical triple-mutant boxes for quantifying cooperativity in intermolecular interactionsChristopher A Hunter, Philip S Jones, Pascale Tiger, et al.
Beilstein Journal of Organic Chemistry|November 13, 2007
The enantiospecific synthesis of (+)-monomorine I using a 5-endo-trig cyclisation strategyMalcolm B Berry, Donald Craig, Philip S Jones, et al.
Drug Discovery Today|September 11, 2014
The Joint European Compound Library: boosting precompetitive researchJérémy Besnard, Philip S Jones, Andrew L Hopkins, et al.
Chemical Communications (Cambridge, England)|July 25, 2003
New building blocks for the assembly of sequence selective molecular zippersChristopher A Hunter, Philip S Jones, Pascale M N Tiger, et al.
Chemmedchem|July 29, 2024
Biological and Medicinal Chemistry Sector of The Royal Society of Chemistry: Promoting Chemistry Learning, Networking and Excellence for Baby Boomers through to Gen Alpha!Sharan K Bagal, Gerard M P Giblin, Adrian Hall, et al.
Anesthesia and Analgesia|December 21, 2006
The hypnotic, electroencephalographic, and antinociceptive properties of nonpeptide ORL1 receptor agonists after intravenous injection in rodentsAlan J Byford, Alison Anderson, Philip S Jones, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Solution and solid-phase synthesis of potent inhibitors of hepatitis C virus NS3 proteinaseRebekah Beevers, Maria G Carr, Philip S Jones, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Structure-activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic propertiesRonald Palin, John K Clark, Louise Evans, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|December 13, 2003
Adherence to advance directives: maybe doctors do not always know bestPhilip S Jones
Drug Discovery Today|October 11, 2016
The SULSA Assay Development Fund: accelerating translation of new biology from academia to pharmaStuart P McElroy, Philip S Jones, Denise V Barrault
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 4, 2003
Chemical triple-mutant boxes for quantifying cooperativity in intermolecular interactionsChristopher A Hunter, Philip S Jones, Pascale Tiger, et al.
Beilstein Journal of Organic Chemistry|November 13, 2007
The enantiospecific synthesis of (+)-monomorine I using a 5-endo-trig cyclisation strategyMalcolm B Berry, Donald Craig, Philip S Jones, et al.
Drug Discovery Today|September 11, 2014
The Joint European Compound Library: boosting precompetitive researchJérémy Besnard, Philip S Jones, Andrew L Hopkins, et al.
Chemical Communications (Cambridge, England)|July 25, 2003
New building blocks for the assembly of sequence selective molecular zippersChristopher A Hunter, Philip S Jones, Pascale M N Tiger, et al.
Chemmedchem|July 29, 2024
Biological and Medicinal Chemistry Sector of The Royal Society of Chemistry: Promoting Chemistry Learning, Networking and Excellence for Baby Boomers through to Gen Alpha!Sharan K Bagal, Gerard M P Giblin, Adrian Hall, et al.
Anesthesia and Analgesia|December 21, 2006
The hypnotic, electroencephalographic, and antinociceptive properties of nonpeptide ORL1 receptor agonists after intravenous injection in rodentsAlan J Byford, Alison Anderson, Philip S Jones, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Solution and solid-phase synthesis of potent inhibitors of hepatitis C virus NS3 proteinaseRebekah Beevers, Maria G Carr, Philip S Jones, et al.
Bioorganic & Medicinal Chemistry|February 6, 2008
Structure-activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic propertiesRonald Palin, John K Clark, Louise Evans, et al.
Pageof 3